Ken Fisher’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.69M | Sell |
310,311
-44,710
| -13% | -$964K | ﹤0.01% | 447 |
|
|
2025
Q1 | $5.9M | Buy |
355,021
+27,516
| +8% | +$457K | ﹤0.01% | 471 |
|
|
2024
Q4 | $6.01M | Buy |
327,505
+132,906
| +68% | +$2.44M | ﹤0.01% | 480 |
|
|
2024
Q3 | $2.99M | Buy |
194,599
+31,980
| +20% | +$492K | ﹤0.01% | 536 |
|
|
2024
Q2 | $2.64M | Buy |
162,619
+9,689
| +6% | +$157K | ﹤0.01% | 550 |
|
|
2024
Q1 | $2.83M | Buy |
152,930
+9,876
| +7% | +$183K | ﹤0.01% | 556 |
|
|
2023
Q4 | $4.48M | Buy |
+143,054
| New | +$4.48M | ﹤0.01% | 503 |
|